STAT3 and cancer: • Inhibits tumor cell proliferation and increases tumor cell senescence • Interferes with CXCR2-induced STAT3 activation in cancer cells • Reduces MMP production by tumor cells • Leads to reduced microvessel density • Single nucleotide polymorphisms affect angiogenesis, tumorigenesis and lung metastasis